ERα expression in T lymphocytes is dispensable for estrogenic effects in bone.

about

ERα expression in T lymphocytes is dispensable for estrogenic effects in bone.

Item

http://www.wikidata.org/entity/Q55493662

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

ERα expression in T lymphocytes is dispensable for estrogenic effects in bone.

@en

ERα expression in T lymphocytes is dispensable for estrogenic effects in bone.

@nl

type

Item

label

ERα expression in T lymphocytes is dispensable for estrogenic effects in bone.

@en

ERα expression in T lymphocytes is dispensable for estrogenic effects in bone.

@nl

prefLabel

ERα expression in T lymphocytes is dispensable for estrogenic effects in bone.

@en

ERα expression in T lymphocytes is dispensable for estrogenic effects in bone.

@nl

P1476

ERα expression in T lymphocytes is dispensable for estrogenic effects in bone.

@en

P2093

A Andersson

http://www.w3.org/2001/XMLSchema#string

H Carlsten

http://www.w3.org/2001/XMLSchema#string

H H Farman

http://www.w3.org/2001/XMLSchema#string

J Wu

http://www.w3.org/2001/XMLSchema#string

J-Å Gustafsson

http://www.w3.org/2001/XMLSchema#string

K H Nilsson

http://www.w3.org/2001/XMLSchema#string

K L Gustafsson

http://www.w3.org/2001/XMLSchema#string

K Sjögren

http://www.w3.org/2001/XMLSchema#string

P Henning

http://www.w3.org/2001/XMLSchema#string

S H Windahl

http://www.w3.org/2001/XMLSchema#string

P2860

The role of estrogen and androgen receptors in bone health and disease

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

Long-term hormone therapy for perimenopausal and postmenopausal women.

Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice.

T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination

Update on estrogens and the skeleton

A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice

The effect of estrogen on bone requires ERα in nonhematopoietic cells but is enhanced by ERα in hematopoietic cells

P304

129-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/JOE-18-0183

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

238

http://www.w3.org/2001/XMLSchema#string

P50

Marie K Lagerquist

Claes Ohlsson

P577

2018-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29848607

http://www.w3.org/2001/XMLSchema#string

P932

6026922

http://www.w3.org/2001/XMLSchema#string